[go: up one dir, main page]

NO20080131L - Fremgangsmate for rensing av IL-18 bindende protein - Google Patents

Fremgangsmate for rensing av IL-18 bindende protein

Info

Publication number
NO20080131L
NO20080131L NO20080131A NO20080131A NO20080131L NO 20080131 L NO20080131 L NO 20080131L NO 20080131 A NO20080131 A NO 20080131A NO 20080131 A NO20080131 A NO 20080131A NO 20080131 L NO20080131 L NO 20080131L
Authority
NO
Norway
Prior art keywords
binding protein
purification
purified
fluid
production
Prior art date
Application number
NO20080131A
Other languages
English (en)
Other versions
NO340957B1 (no
Inventor
Henri Kornmann
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of NO20080131L publication Critical patent/NO20080131L/no
Publication of NO340957B1 publication Critical patent/NO340957B1/no

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/286Phases chemically bonded to a substrate, e.g. to silica or to polymers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30Processes for preparing, regenerating, or reactivating
    • B01J20/32Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3244Non-macromolecular compounds
    • B01J20/3246Non-macromolecular compounds having a well defined chemical structure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804Affinity chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Oppfinnelsen vedrører en fremgangsmåte for fremstilling av renset IL-18 bindende protein (IL-18BP) fra et fluid som omfatter affinitetskromatografi.
NO20080131A 2005-06-10 2008-01-08 Anvendelse av IL-18 bindende protein samt fremgangsmåte for rensing av proteinet NO340957B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05105124 2005-06-10
US69041405P 2005-06-14 2005-06-14
PCT/EP2006/063029 WO2006131550A1 (en) 2005-06-10 2006-06-08 Process for the purification of il-18 binding protein

Publications (2)

Publication Number Publication Date
NO20080131L true NO20080131L (no) 2008-03-07
NO340957B1 NO340957B1 (no) 2017-07-31

Family

ID=34940147

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080131A NO340957B1 (no) 2005-06-10 2008-01-08 Anvendelse av IL-18 bindende protein samt fremgangsmåte for rensing av proteinet

Country Status (17)

Country Link
US (1) US8217152B2 (no)
EP (1) EP1891088B1 (no)
JP (1) JP5091127B2 (no)
AT (1) ATE529433T1 (no)
AU (1) AU2006256763B2 (no)
CA (1) CA2610804C (no)
CY (1) CY1112312T1 (no)
DK (1) DK1891088T3 (no)
ES (1) ES2375831T3 (no)
HR (1) HRP20110948T1 (no)
IL (1) IL187935A (no)
NO (1) NO340957B1 (no)
PL (1) PL1891088T3 (no)
PT (1) PT1891088E (no)
RS (1) RS52273B (no)
SI (1) SI1891088T1 (no)
WO (1) WO2006131550A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0408246A (pt) 2003-03-11 2006-03-01 Applied Research Systems vetores de expressão que compreendem o promotor ie2 do mcmv
US20080076708A1 (en) * 2003-05-13 2008-03-27 Valter Altarocca Active Variants of the Il-18 Binding Protein and Medical Uses Thereof
ATE484591T1 (de) 2003-10-21 2010-10-15 Merck Serono Sa Minimale dna sequenz, die als chromatin-isolator wirkt, und deren verwendung für die protein- expression
PT1689777E (pt) 2003-11-05 2007-05-31 Ares Trading Sa Processo para a purificação da proteína de ligação a il-18
HRP20070474T3 (en) 2004-03-01 2007-11-30 Ares Trading S.A. Use of a serum-free cell culture medium for the production of il-18bp in mammalian cells
EP1761552B1 (en) * 2004-06-29 2008-09-17 Ares Trading S.A. Process for the purification of il-18 binding protein
GB0416699D0 (en) 2004-07-27 2004-09-01 Prometic Biosciences Ltd Prion protein ligands and methods of use
PL2267024T3 (pl) * 2005-06-03 2012-10-31 Ares Trading Sa Wytwarzanie rekombinowanego białka wiążącego IL-18
CA2611734A1 (en) * 2005-06-10 2006-12-14 Prometic Biosciences Limited Triazines as protein binding ligands
WO2012122484A1 (en) * 2011-03-09 2012-09-13 Roberto Polakiewicz Methods and reagents for creating monoclonal antibodies

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737462A (en) * 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4588585A (en) * 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
US4959314A (en) * 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
US5116943A (en) * 1985-01-18 1992-05-26 Cetus Corporation Oxidation-resistant muteins of Il-2 and other protein
US5017691A (en) * 1986-07-03 1991-05-21 Schering Corporation Mammalian interleukin-4
US4879111A (en) * 1986-04-17 1989-11-07 Cetus Corporation Treatment of infections with lymphokines
US4965195A (en) * 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
US4904584A (en) * 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
DE3902948A1 (de) * 1989-02-01 1990-08-09 Telefunken Fernseh & Rundfunk Verfahren zur uebertragung eines signals
SG63617A1 (en) 1991-01-18 1999-03-30 Amgen Boulder Inc Methods for treating tumar necrosis factor mediated diseases
US6117996A (en) * 1995-09-20 2000-09-12 Novo Nordisk A/S Triazine based ligands and use thereof
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
US7220717B2 (en) * 1997-08-14 2007-05-22 Yeda Research And Development Company Ltd. Interleukin-18 binding proteins, their preparation and use
GB9910807D0 (en) * 1999-05-10 1999-07-07 Prometic Biosciences Limited Novel detoxification agents and their use
JP4944324B2 (ja) 1999-07-13 2012-05-30 ボルダー バイオテクノロジー, インコーポレイテッド 免疫グロブリン融合タンパク質
IL131047A0 (en) 1999-07-22 2001-01-28 Yeda Res & Dev Use of il-18 inhibitors
DK1257292T3 (da) 2000-02-21 2011-07-18 Merck Serono Sa Anvendelse af IL-18-inhibitorer
KR100798545B1 (ko) 2000-05-05 2008-01-28 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. 죽상경화증의 치료 또는 예방을 위한 il-18 저해물질의용도
ATE380558T1 (de) 2001-01-29 2007-12-15 Serono Lab Verwendung von il-18 hemmern zur behandlung und/oder prävention von herzkrankheiten
DE60208692T2 (de) 2001-03-08 2006-07-13 Ares Trading S.A. Interleukin -18 mutantenproteine, deren herstellung und verwendung
US20030008822A1 (en) 2001-05-16 2003-01-09 Charles Dinarello Use of IL-18 inhibitors for the treatment or prevention of sepsis
HRP20030842B1 (hr) 2001-05-25 2017-06-02 Ares Trading S.A. UPOTREBA IL-18 INHIBITORA ZA LIJEČENJE I PREVENCIJU OZLJEDA CNS-a
UA78516C2 (en) 2001-08-10 2007-04-10 Applied Research Systems Use of inhibitors of il-18 for treatment and/or prevention of hypersensitivity disorders, and in particular of delayed-type hypersensitivity
RS51755B (sr) 2002-03-22 2011-12-31 Laboratoires Serono Sa. Korišćenje inhibitora il-18 za lečenje i/ili prevenciju perifernih vaskularnih bolesti
BRPI0408246A (pt) 2003-03-11 2006-03-01 Applied Research Systems vetores de expressão que compreendem o promotor ie2 do mcmv
US20080076708A1 (en) * 2003-05-13 2008-03-27 Valter Altarocca Active Variants of the Il-18 Binding Protein and Medical Uses Thereof
ATE484591T1 (de) * 2003-10-21 2010-10-15 Merck Serono Sa Minimale dna sequenz, die als chromatin-isolator wirkt, und deren verwendung für die protein- expression
PT1689777E (pt) 2003-11-05 2007-05-31 Ares Trading Sa Processo para a purificação da proteína de ligação a il-18
HRP20070474T3 (en) * 2004-03-01 2007-11-30 Ares Trading S.A. Use of a serum-free cell culture medium for the production of il-18bp in mammalian cells
EP1761552B1 (en) 2004-06-29 2008-09-17 Ares Trading S.A. Process for the purification of il-18 binding protein
PL2267024T3 (pl) 2005-06-03 2012-10-31 Ares Trading Sa Wytwarzanie rekombinowanego białka wiążącego IL-18
CA2611734A1 (en) * 2005-06-10 2006-12-14 Prometic Biosciences Limited Triazines as protein binding ligands

Also Published As

Publication number Publication date
AU2006256763A1 (en) 2006-12-14
US20080200658A1 (en) 2008-08-21
WO2006131550A1 (en) 2006-12-14
PL1891088T3 (pl) 2012-03-30
RS52273B (sr) 2012-10-31
CA2610804C (en) 2013-11-19
NO340957B1 (no) 2017-07-31
PT1891088E (pt) 2011-12-19
CA2610804A1 (en) 2006-12-14
SI1891088T1 (sl) 2012-02-29
HRP20110948T1 (hr) 2012-01-31
AU2006256763B2 (en) 2012-08-02
IL187935A (en) 2015-10-29
IL187935A0 (en) 2008-03-20
EP1891088A1 (en) 2008-02-27
ES2375831T3 (es) 2012-03-06
DK1891088T3 (da) 2012-01-30
ATE529433T1 (de) 2011-11-15
JP2008542432A (ja) 2008-11-27
CY1112312T1 (el) 2015-12-09
EP1891088B1 (en) 2011-10-19
US8217152B2 (en) 2012-07-10
JP5091127B2 (ja) 2012-12-05

Similar Documents

Publication Publication Date Title
NO20080131L (no) Fremgangsmate for rensing av IL-18 bindende protein
NO20062545L (no) Fremgangsmate for rensing av IL-18-bindende protein
NO20070483L (no) Prosses for rensing av IL-18 bindende protein.
ATE481482T1 (de) Verfahren zur vorbereitenden rna-reinigung mittels hplc
WO2007081851A3 (en) Affinity chromatography matrices and methods of making and using the same
NO20076672L (no) Produksjon av rekombinant IL-18 bindingsprotein
DE602004016796D1 (de) Reinigungverfahren für Synthesegas
EP1568710A3 (en) Antibody purification method
ZA200900836B (en) Process for the purification of FC-fusion proteins
DK1809663T3 (da) Fremgangsmåde til oprensning af FSH
WO2007016635A3 (en) Process for the purification of coenzyme q10
ATE496935T1 (de) Verfahren zur aufreinigung hydrophober proteine
WO2011090720A3 (en) Purification of proteins
SE0303532D0 (sv) Purification of immunoglobulins
DK1817342T3 (da) Fremgangsmåde til affinitetsrensning
MY157846A (en) Process for the purification of fc-containing proteins
ITMI20051085A1 (it) Metodo di purificazione del cefotetan
IL199752A0 (en) Purification of taci-fc
EP1842908A4 (en) PROCESS FOR PREPARING CLEANED LIPASE
EP2129461A4 (en) Purification of immunoglobulins
CY1116631T1 (el) Καθαρισμος πρωτεϊνων με τεχνικη μη-συγγενειας